Elevated serum level of interleukin (IL)-18, interferon (IFN)-c and soluble fas in patients with pulmonary complications in tuberculosis

Acta Microbiologica et Immunologica Hungarica

Volumn 54, Issue 1, 2007, Pages 65-77

  El Masry, S ^a   Lotfy, M ^a   Nasif, W A ^a   El Kady, I M ^a   Al Badrawy, M ^b  

^a MENOUFIA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Interferon gamma; Interleukin 18; Mycobacterium tuberculosis; sFas

Indexed keywords

MYCOBACTERIUM TUBERCULOSIS;

BIOLOGICAL MARKER; FAS ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 18;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG TUBERCULOSIS; MALE; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS;

ADULT; AGED; ANTIGENS, CD95; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-18; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 34250656552     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.54.2007.1.7     Document Type: Article

References (37)

1. Casarini, M., Ameglio, F., Alemanna, L., Zangrilli, P., Mattia, P., Paone, G., Bisetti, A., Giosue, S.: Cytokine levels correlate with a radiologic score in active pulmonary tuberculosis. Am J Respir Crit Care Med 159, 143-148 (1999).
2. Appelberg, R.: Mycobacterial infection primes T cells and macrophages for enhanced recruitment of neutrophils. J Leukoc Biol 57, 472-477 (1992).
3. Condos, R., Rom, W. N., Liu, Y.M., Schluger, N. W.: Local immune responses correlate with presentation and outcome in tuberculosis. Am J Respir Crit Care Med 157, 729-735 (1998).
4. Jones, G. S., Amirault, J. H., Andersen, B. R.: Killing of Mycobacterium tuberculosis by neutrophils: a nonoxidative process. J Infect Dis 162, 700-704 (1990).
5. Cox, G., Crossley, J., Xing, Z.: Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary inflammation in vivo. Am J Respir Cell Mol Biol 12, 232-237 (1995).
6. Homburg, C. H., Haas, E. M., von Dem Borne, A. E., Verhoeven, A. J., Reutelingsperger, C. M., Roos, D.: Human neutrophils lose their surface Fc-γ RIII and acquire annexin V binding sites during apoptosis. Blood 85, 532-540 (1995).
7. Savill, J. S., Wyllie, A. H., Henson, J. E., Walport, M. H., Henson, P. M., Haslett, C.: Macrophage phagocytosis of aging neutrophils in Inflammation: programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 83, 865-867 (1989).
8. Dransfield, I., Buckle, A. M., Savill, J. S., McDowall, A., Haslett, C., Hogg, N.: Neutrophil apoptosis is associated with a reduction in CD16 (FC-γIII) expression. J Immunol 153, 1254-1263 (1994).
9. Liles, W. C., Kiener, P. A., Ledbetter, J. A., Aruffo, A., Klebanoff, S. J.: Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med 184, 429-440 (1996).
10. Mustafa, T., Bjune, T. G., Jonsson, R., Pando, R. H., Nilsen, R.: Increased expression of Fas ligand in human tuberculosis and leprosy lesions: a potential novel mechanism of immune evasion in mycobacterial infection. Scand J Immunol 54(6), 630-639 (2001).
11. Colotta, F., Polentarutti, S., Sozzani, S., Mantovani, A.: Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80, 2012-2020 (1992).
12. Watson, R., Redmond, H. P., Wang, J. H., Condron, C., Bouchier-Hayes, D.: Neutrophils undergo apoptosis following ingestion of Escherichia coli. J Immunol 156, 3986-3992 (1996).
13. Ribeiro-Rodrigues, R., Resende, C. T., Johnson, J. L., Ribeiro, F., Palaci, M., Sa, R. T., Maciel, E. L., Pereira Lima, F. E., Dettoni, V., Toossi, Z., Boom, W. H., Dietze, R., Ellner, J. J., Hirsch, C. S.: Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance. Clin Diagn Lab Immunol 9(4), 818-823 (2002).
14. Okamura, H., Tsutsui, H., Kashiwamura, T., Yoshimoto, K., Nakanishi, T.: Interlukin-18: an cytokine that augments both innate and acquired immunity. Adv Immunol 70, 281-312 (1998).
15. Sartono, E.: In Th2-biased lymphatic filarial patients, responses to purified protein derivate of Mycobacterium tuberculosis remain Th1. Eur J Immunol 26, 501 (1996).
16. Jodo, K., Nakajima, M., Nakayama, O., Kayagak, O., Koike, E.: Elevated serum levels of soluble Fas\Apo-1 (CD95) in patients with hepatocellular carcinoma. Clin Exp Immunol 112(2), 166 (1998).
17. van Crevel, R., Ottenhoff, T. H. M., van der Meer, J. W. M.: Innate immunity to Mycobacterium tuberculosis. Clinical Microbiology Reviews 15(2), 294-309 (2002).
18. Morosini, M., Meloni, F., Marone-Bianco, A., Paschetto, E., Uccelli, M., Pozzi, E., Fietta, A.: The assessment of IFN-gamma and its regulatory cytokines in the plasma and broncho-alveolar lavage fluid of patients with active pulmonary tuberculosis. Int J Tuberc Lung Dis 7(10), 994-1000 (2003).
19. Fujiuchi, S., Matsumoto, H., Yamazaki, Y., Nakata, H., Takahashi, M., Nakao, S., Takeda, A., Okamoto, K., Fujita, Y., Fujikane, T., Shimizu, T.: Impaired interleukin-1beta converting enzyme (ICE) activity in patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 7(11), 1109-1112 (2003).
20. Dinarello, C. A., Novick, D., Puren, A. J., Fantuzzi, G., Shapiro, L., Muhl, H., Yoon, D. Y., Reznikov, L. L., Kim, S. H., Rubinstein, M.: Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukoc Biol 63, 658-664 (1998).
21. O'Neill, L. A., Greene, C.: Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol 63, 650-657 (1998).
22. Netea, M. G., Kullberg, B. J., Verschueren, I., Van Der Meer, J. W.: Interleukin-18 induces production of proinflammatory cytokines in mice: No intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta. Eur J Immunol 30, 3057-3060 (2000).
23. + human blood mononuclear cells. J Clin Investig 101, 711-721 (1998).
24. Sugawara, I., Yamada, H., Kaneko, H., Mizuno, S., Takeda, K., Akira, S.: Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect Immun 67, 2585-2589 (1999).
25. Kobayashi, K., Kai, M., Gidoh, M., Nakata, N., Endoh, M., Singh, R. P., Kasama, T., Saito, H.: The possible role of interleukin (IL)-12 and interferon-gamma-inducing factor/IL-18 in protection against experimental Mycobacterium leprae infection in mice. Clin Immunol Immunopathol 88, 226-231 (1998).
26. Vankayalapati, R., Wizel, B., Weis, S. E., Samten, B., Girard, W. M., Barnes, P. F.: Production of interleukin-18 in human tuberculosis. J Infect Dis 182, 234-239 (2000).
27. Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., Bloom, B. R.: An Essential Role for Interferon-γ in Resistance to Mycobacterium tuberculosis Infection. J Exp Med 178, 2249-2254 (1993).
28. Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A., Stewart, T. A.: Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259, 1739 (1993).
29. Song, C. H., Lee, J. S., Nam, H. H., Kim, J. M., Suhr, J. W., Jung, S. S., Na, M. J., Paik, T. H., Kim, H. J., Park, J. K., Jo, E. K.: IL-18 production in human pulmonary and pleural tuberculosis. Scand J Immunol 56(6), 611-618 (2002).
30. Tang, S., Xiao, H., Fan, Y., Wu, F., Zhang, Z., Li, H., Yang, Y.: Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi 25(6), 325-329 (2002).
31. Marsik, C., Halama, T., Cardona, F., Wlassits, W., Mayr, F., Pleiner, J., Jilma, B.: Regulation of Fas (Apo-1, CD95) and Fas ligand expression in leukocytes during systemic inflammation in humans. Shock 20(6), 493-496 (2003).
32. Sibiryak, S. V., Yusupova, R. S., Kayumova, E. U.: Fas/Apo1 (CD95) Antigen Expression on the peripheral blood lymphocytes in healthy donors and pulmonary tuberculosis patients. Rus J Immunol 4(1), 34-42 (1999).
33. Mustafa, T., Phyu, S., Nilsen, R., Bjune, G., Jonsson, R.: Increased expression of Fas ligand on Mycobacterium tuberculosis infected macrophages: a potential novel mechanism of immune evasion by Mycobacterium tuberculosis? Inflammation 23(6), 507-521 (1999).
34. Park, D. R., Thomsen, A. R., Frevert, C. W., Pham, U., Skerrett, S. J., Kiener, P. A., Liles, W. C.: Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived Macrophages. J Immunol 170, 6209-6216 (2003).
35. Mogga, S. J., Mustafa, T., Sviland, L., Nilsen, R.: Increased Bcl-2 and reduced Bax expression in infected macrophages in slowly progressive primary murine Mycobacterium tuberculosis infection. Scand J Immunol 56, 383-391 (2002).
36. Moura, E. P., Toledo, V. P. C. P., Oliveira, M. H. P., Spíndola-de-Miranda, S., Andrade, H. M., Guimarães, T. M. P. D.: Pulmonary tuberculosis: evaluation of interferon-γ levels as an immunological healing marker based on the response to the Bacillus Calmette-Guerin. Mem Inst Oswaldo Cruz, Rio de Janeiro 99(3), 283-287 (2004).
37. Oddo, M., Renno, T., Attinger, A., Bakker, T., MacDonald, H. R., Meylan, P. R.: Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol 160(11), 5448-5454 (1998).